Follow The Filings

EVLV Evolv Technologies

Evolv Technologies earnings company data as of 4:47 AM ET 10/6

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by EVLV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EVLV insider trades
  • $750K bought by 6 insiders
  • None no sales outside a trading plan
  • $7.8M sold by 2 insiders under 10b5-1 plans
  1. Richard A Shapiro Director
    Buy
    $162K 32,600 shares at $4.96
    Traded Sep 4 Filed Sep 9
    ↗
  2. Michael Ellenbogen Director
    Planned sale
    $451K 80,752 shares at $5.59 3.7% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  3. Henrik Kuhl Director
    Buy
    $86K 15,000 shares at $5.73 New stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. Neil Glat Director
    Buy
    $49K 8,500 shares at $5.74 +3.5% to stake
    Traded Aug 14 Filed Aug 18
    ↗
  5. Michael Ellenbogen Director
    Planned sale
    $480K 80,745 shares at $5.94 3.7% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  6. Michael Ellenbogen Director
    Planned sale
    $501K 80,745 shares at $6.21 3.7% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  7. Michael Ellenbogen Director
    Planned sale
    $455K 80,745 shares at $5.63 3.7% of stake
    Traded May 15 Filed May 18
    ↗
  8. Michael Ellenbogen Director
    Planned sale
    $510K 80,745 shares at $6.32 3.7% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  9. Michael Ellenbogen Director
    Planned sale
    $468K 91,771 shares at $5.10 4.2% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  10. Michael Ellenbogen Director
    Planned sale
    $442K 80,745 shares at $5.47 3.7% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  11. Michael Ellenbogen Director
    Planned sale
    $501K 80,745 shares at $6.20 3.7% of stake
    Traded Jan 16 Filed Jan 20
    ↗
  12. Michael Ellenbogen Director
    Planned sale
    $558K 80,745 shares at $6.91 3.7% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  13. Robert E Marshall Chief Revenue Officer
    Buy
    $42K 7,000 shares at $6.06 New stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  14. John Kedzierski CEO
    Buy
    $47K 8,000 shares at $5.91 New stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
  15. Kevin M. Charlton Director
    Buy
    $85K 15,000 shares at $5.68 +52% to stake
    Traded Nov 21, 2025 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 option exercises, 5 sales to cover taxes, and 3 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.